The PE Ratio as of July 2024 (TTM) for Surrozen, Inc. (SRZN) is -0.47

According to Surrozen, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.47. This represents a change of -2.98% compared to the average of -0.48 of the last 4 quarters.

Surrozen, Inc. (SRZN) Historical PE Ratio (quarterly & annually)

How has SRZN PE Ratio performed in the past?

The mean historical PE Ratio of Surrozen, Inc. over the last ten years is -2.32. The current -0.47 PE Ratio has changed 1.92% with respect to the historical average. Over the past ten years (40 quarters), SRZN's PE Ratio was at its highest in in the December 2022 quarter at 0.60. The PE Ratio was at its lowest in in the March 2022 quarter at -280.88.

Surrozen, Inc. (SRZN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Surrozen, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Surrozen, Inc. (SRZN) Average PE Ratio

How has SRZN PE Ratio performed in the past?

The current PE Ratio of Surrozen, Inc. (SRZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Surrozen, Inc. (SRZN) PE Ratio vs. Peers

How is SRZN’s PE Ratio compared to its peers?

Surrozen, Inc.’s PE Ratio is less than Bolt Biotherapeutics, Inc. (-0.45), greater than Larimar Therapeutics, Inc. (-11.31), greater than Keros Therapeutics, Inc. (-9.61), greater than Kezar Life Sciences, Inc. (-0.48), greater than Processa Pharmaceuticals, Inc. (-4.19), less than NexImmune, Inc. (-0.06), less than Evelo Biosciences, Inc. (-0.00), greater than Tempest Therapeutics, Inc. (-1.27), greater than Replimune Group, Inc. (-2.95), greater than Nuvectis Pharma, Inc. (-5.13), less than Lyra Therapeutics, Inc. (-0.29), greater than Kronos Bio, Inc. (-0.68), greater than Gossamer Bio, Inc. (-1.46), less than ERYTECH Pharma S.A. (27.92), greater than Aptorum Group Limited (-6.66), less than Unicycive Therapeutics, Inc. (-0.43), greater than Armata Pharmaceuticals, Inc. (-1.32), less than CytomX Therapeutics, Inc. (7.44), greater than Instil Bio, Inc. (-0.66), greater than Neoleukin Therapeutics, Inc. (-0.98), less than Spero Therapeutics, Inc. (3.28), greater than Assembly Biosciences, Inc. (-1.60),

Build a custom stock screener for Surrozen, Inc. (SRZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surrozen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Surrozen, Inc. (SRZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Surrozen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.